Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome: a Placebo-controlled Randomized Double-blind Trial

NCT07173062 is registered in ClinicalTrials.gov with Universidade do Porto as lead sponsor.

NCT NCT07173062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07173062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome: a Placebo-controlled Randomized Double-blind Trial
Lead sponsor
Universidade do Porto
Phase
Not applicable
Overall status
Recruiting
Start date
March 11, 2025
Completion date
August 31, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

albuminuria, chronic kidney disease(ckd), coronary arterial disease (cad), diabetes mellitus, myocardial infarction (mi), peripheral artery disease (pad), stroke